Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma
NCT02694965
·
clinicaltrials.gov ↗
COMPLETED
Status
122
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
OTHER:
observational
Sponsor
Duke University